Trial Profile
Phase II trial of elinogrel in patients with stable coronary artery disease and high platelet reactivity who did not respond to clopidogrel.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Nov 2008
Price :
$35
*
At a glance
- Drugs Elinogrel (Primary) ; Aspirin; Clopidogrel
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Pharmacodynamics
- Sponsors Portola Pharmaceuticals
- 11 Nov 2008 Results presented at the American Heart Association's Annual Scientific Sessions 2008.
- 11 Nov 2008 New trial record.